Contact
Please use this form to send email to PR contact of this press release:
FutureLand Corp. (FUTL) Purchases 20% of Apotheca Biosciences - Developing Cutting-Edge Cannabinoids Medical Products, Nutraceuticals & Formulation Technologies
TO: